Detalles de la búsqueda
1.
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study.
Ann Oncol
; 33(4): 416-425, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026412
2.
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma.
Ann Oncol
; 32(9): 1127-1136, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34082019
3.
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Ann Oncol
; 30(2): 250-258, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30566590
4.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(1): 34-43, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475943
5.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(1): 19-33, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475956
6.
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.
Ann Oncol
; 29(5): 1220-1226, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438463
7.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Ann Oncol
; 29(10): 2052-2060, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30052729
8.
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Ann Oncol
; 26(10): 2097-101, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26216386
9.
Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors.
Ann Oncol
; 25(11): 2272-2277, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149706
10.
Impact of extranodal extension on prognosis in lymph node-positive gastric cancer.
Br J Surg
; 101(12): 1576-84, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25223244
11.
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.
Br J Cancer
; 109(9): 2309-15, 2013 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24084771
12.
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
Br J Cancer
; 108(6): 1245-51, 2013 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23449357
13.
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis.
Ann Oncol
; 24(11): 2850-4, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23942775
14.
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.
Br J Cancer
; 106(6): 1039-44, 2012 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22343617
15.
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer.
Br J Cancer
; 106(10): 1591-7, 2012 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22516947
16.
Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.
Invest New Drugs
; 30(6): 2377-83, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22270258
17.
Effect of supplementation of multi-microbe probiotic product on growth performance, apparent digestibility, cecal microbiota and small intestinal morphology of broilers.
J Anim Physiol Anim Nutr (Berl)
; 96(4): 618-26, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21699585
18.
Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients.
Int J Oral Maxillofac Surg
; 51(6): 713-723, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483028
19.
Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.
Br J Cancer
; 104(4): 605-12, 2011 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21326246
20.
Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines.
Br J Dermatol
; 162(2): 371-9, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19903175